AP295A - 3-Piperidinylmethylcarboxylate substituted indoles. - Google Patents

3-Piperidinylmethylcarboxylate substituted indoles. Download PDF

Info

Publication number
AP295A
AP295A APAP/P/1992/000417A AP9200417A AP295A AP 295 A AP295 A AP 295A AP 9200417 A AP9200417 A AP 9200417A AP 295 A AP295 A AP 295A
Authority
AP
ARIPO
Prior art keywords
methyl
indole
compound
group
piperidinyl
Prior art date
Application number
APAP/P/1992/000417A
Other languages
English (en)
Other versions
AP9200417A0 (en
Inventor
Alexander William Oxford
John Willian Frank Whitehead
John Knight
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB919103862A priority Critical patent/GB9103862D0/en
Priority to AU12094/92A priority patent/AU645402B2/en
Priority to AT92102900T priority patent/ATE142205T1/de
Priority to ES92102900T priority patent/ES2091963T3/es
Priority to DE69213276T priority patent/DE69213276T2/de
Priority to PCT/EP1992/000371 priority patent/WO1992014727A1/en
Priority to EP92102900A priority patent/EP0501322B1/en
Priority to JP4504653A priority patent/JPH06505238A/ja
Priority to HU9302414A priority patent/HUT65486A/hu
Priority to CA002105179A priority patent/CA2105179A1/en
Priority to IE056792A priority patent/IE920567A1/en
Priority to IL10104292A priority patent/IL101042A/en
Priority to MX9200762A priority patent/MX9200762A/es
Priority to NZ241704A priority patent/NZ241704A/xx
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to APAP/P/1992/000417A priority patent/AP295A/en
Priority to CN92110050A priority patent/CN1083059A/zh
Publication of AP9200417A0 publication Critical patent/AP9200417A0/xx
Priority to FI933697A priority patent/FI933697A0/fi
Priority to NO933015A priority patent/NO933015D0/no
Application granted granted Critical
Publication of AP295A publication Critical patent/AP295A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
APAP/P/1992/000417A 1991-02-25 1992-08-17 3-Piperidinylmethylcarboxylate substituted indoles. AP295A (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GB919103862A GB9103862D0 (en) 1991-02-25 1991-02-25 Chemical compounds
PCT/EP1992/000371 WO1992014727A1 (en) 1991-02-25 1992-02-21 3-piperidinylmethylcarboxylate substituted indoles
DE69213276T DE69213276T2 (de) 1991-02-25 1992-02-21 Substituierte Piperidimylmethyl-Ester von 3-Indolcarbonsäure
AT92102900T ATE142205T1 (de) 1991-02-25 1992-02-21 Substituierte piperidimylmethyl-ester von 3- indolcarbonsäure
EP92102900A EP0501322B1 (en) 1991-02-25 1992-02-21 3-Piperidinylmethylcarboxylate substituted indoles
JP4504653A JPH06505238A (ja) 1991-02-25 1992-02-21 ３−ピペリジニルメチルカルボキシレート置換インドール
HU9302414A HUT65486A (en) 1991-02-25 1992-02-21 Process for producing piperidinyl methylesters of indol-3-carboxylic acid derivatives and pharmaceutical preparations containing them
CA002105179A CA2105179A1 (en) 1991-02-25 1992-02-21 3-piperidinylmethylcarboxylate substituted indoles
AU12094/92A AU645402B2 (en) 1991-02-25 1992-02-21 3-piperidinylmethylcarboxylate substituted indoles
ES92102900T ES2091963T3 (es) 1991-02-25 1992-02-21 Indoles 3-piperidinilmetilcarboxilato sustituidos.
IE056792A IE920567A1 (en) 1991-02-25 1992-02-24 3-piperidinylmethylcarboxylate substituted indoles
IL10104292A IL101042A (en) 1991-02-25 1992-02-24 Indulators are converted by piperidinylmethylcarboxylate, their preparation and pharmaceutical preparations containing them
MX9200762A MX9200762A (es) 1991-02-25 1992-02-24 Derivados de indol, procedimiento para su reparacion y composicion que los contiene.
NZ241704A NZ241704A (en) 1991-02-25 1992-02-24 3 piperidinylmethylcarboxylate indole derivatives and pharmaceutical compositions thereof
APAP/P/1992/000417A AP295A (en) 1991-02-25 1992-08-17 3-Piperidinylmethylcarboxylate substituted indoles.
CN92110050A CN1083059A (zh) 1991-02-25 1992-08-24 3-哌啶甲基羧酸酯取代的吲哚
FI933697A FI933697A0 (fi) 1991-02-25 1993-08-23 3-piperidinylmetylkarboxylatsubstituerade indoler
NO933015A NO933015D0 (no) 1991-02-25 1993-08-24 3-piperidinylmetalkarboksylat-substituerte indoler

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB919103862A GB9103862D0 (en) 1991-02-25 1991-02-25 Chemical compounds
APAP/P/1992/000417A AP295A (en) 1991-02-25 1992-08-17 3-Piperidinylmethylcarboxylate substituted indoles.
CN92110050A CN1083059A (zh) 1991-02-25 1992-08-24 3-哌啶甲基羧酸酯取代的吲哚

Publications (2)

Publication Number Publication Date
AP9200417A0 AP9200417A0 (en) 1992-10-31
AP295A true AP295A (en) 1993-12-29

Family

ID=36790873

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1992/000417A AP295A (en) 1991-02-25 1992-08-17 3-Piperidinylmethylcarboxylate substituted indoles.

Country Status (18)

Country Link
EP (1) EP0501322B1 (es)
JP (1) JPH06505238A (es)
CN (1) CN1083059A (es)
AP (1) AP295A (es)
AT (1) ATE142205T1 (es)
AU (1) AU645402B2 (es)
CA (1) CA2105179A1 (es)
DE (1) DE69213276T2 (es)
ES (1) ES2091963T3 (es)
FI (1) FI933697A0 (es)
GB (1) GB9103862D0 (es)
HU (1) HUT65486A (es)
IE (1) IE920567A1 (es)
IL (1) IL101042A (es)
MX (1) MX9200762A (es)
NO (1) NO933015D0 (es)
NZ (1) NZ241704A (es)
WO (1) WO1992014727A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2126354C (en) * 1991-12-21 2006-07-11 Gareth John Sanger Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US20020128172A1 (en) 1991-12-21 2002-09-12 Smithkline Beecham Plc Use of 5-HT4 modulators for the manufacture of a medicament for the treatment of the bladder diseases
US5852014A (en) * 1992-03-12 1998-12-22 Smithkline Beecham P.L.C. Condensed indole derivatives as 5HT4 -receptor antagonists
MY110110A (en) * 1992-03-12 1998-01-27 Smithkline Beecham Plc Pharmaceuticals in the treatment of gastrointestinal disorders, cardiovascular disorders and cns disorders
WO1993024117A2 (en) * 1992-05-23 1993-12-09 Smithkline Beecham Plc Medicaments for the treatment of anxiety
AU4350493A (en) * 1992-06-27 1994-01-24 Smithkline Beecham Plc Medicaments containing 5-ht4 receptor antagonists
MX9305947A (es) * 1992-09-29 1994-06-30 Smithkline Beecham Plc Compuestos antagonistas del receptor 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que las contienen.
MX9306311A (es) * 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
GB9221468D0 (en) * 1992-10-13 1992-11-25 Smithkline Beecham Plc Pharmaceuticals
US5726187A (en) * 1992-10-16 1998-03-10 Smithkline Beecham Plc N-alkylpiperidinyl-4-methyl carboxylic esters/amides of condensed ring systems as 5-HT4 receptor antagonists
KR950704328A (ko) * 1992-11-05 1995-11-17 데이비드 로버츠 5-HT₄ 수용체 길항제로서의 피페리딘 유도체(Piperidine Derivatives as 5-HT₄ Receptor Antagonists)
GB9301660D0 (en) * 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9310582D0 (en) * 1993-05-22 1993-07-07 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) * 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
IT1275903B1 (it) * 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
GB9702194D0 (en) 1997-02-04 1997-03-26 Lilly Co Eli Sulphonide derivatives
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
GB9725933D0 (en) * 1997-12-05 1998-02-04 Smithkline Beecham Plc Pharmaceuticals
IL154279A0 (en) * 2000-08-07 2003-09-17 Glaxosmithkline Lab Sas Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
EA200301143A1 (ru) * 2001-04-20 2004-02-26 Уайт Производные гетероциклилалкокси-, алкилтио- и -алкиламинобензазола в качестве лигандов 5-гидрокситриптамина-6
CA2444095A1 (en) * 2001-04-20 2002-10-31 Wyeth Heterocyclyloxy-, -thioxy- and -aminobenzazole derivatives as 5-hydroxytryptamine-6 ligands
GB0211230D0 (en) 2002-05-16 2002-06-26 Medinnova Sf Treatment of heart failure
EP2445877B1 (en) * 2008-12-03 2014-07-23 Nanotherapeutics, Inc. Bicyclic compounds and methods of making and using same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2152049A (en) * 1983-12-23 1985-07-31 Sandoz Ltd Benzoic acid derivative
EP0229391A1 (en) * 1985-12-27 1987-07-22 Eisai Co., Ltd. Piperidine derivate, its use and pharmaceutical composition containing it
EP0429984A2 (en) * 1989-11-17 1991-06-05 Nisshin Flour Milling Co., Ltd. Indole derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60123485A (ja) * 1983-12-08 1985-07-02 Yoshitomi Pharmaceut Ind Ltd インド−ル−３−カルボキサミド誘導体
GB8527052D0 (en) * 1985-11-02 1985-12-04 Beecham Group Plc Compounds

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2152049A (en) * 1983-12-23 1985-07-31 Sandoz Ltd Benzoic acid derivative
EP0229391A1 (en) * 1985-12-27 1987-07-22 Eisai Co., Ltd. Piperidine derivate, its use and pharmaceutical composition containing it
EP0429984A2 (en) * 1989-11-17 1991-06-05 Nisshin Flour Milling Co., Ltd. Indole derivatives

Also Published As

Publication number Publication date
WO1992014727A1 (en) 1992-09-03
EP0501322A1 (en) 1992-09-02
CA2105179A1 (en) 1992-08-26
ATE142205T1 (de) 1996-09-15
AU1209492A (en) 1992-09-15
ES2091963T3 (es) 1996-11-16
DE69213276D1 (de) 1996-10-10
IL101042A (en) 1996-06-18
IE920567A1 (en) 1992-08-26
FI933697A (fi) 1993-08-23
FI933697A0 (fi) 1993-08-23
HU9302414D0 (en) 1993-11-29
EP0501322B1 (en) 1996-09-04
NZ241704A (en) 1993-11-25
AU645402B2 (en) 1994-01-13
NO933015L (no) 1993-08-24
IL101042A0 (en) 1992-11-15
HUT65486A (en) 1994-06-28
GB9103862D0 (en) 1991-04-10
MX9200762A (es) 1992-08-01
NO933015D0 (no) 1993-08-24
CN1083059A (zh) 1994-03-02
JPH06505238A (ja) 1994-06-16
AP9200417A0 (en) 1992-10-31
DE69213276T2 (de) 1997-01-23

Similar Documents

Publication Publication Date Title
AP295A (en) 3-Piperidinylmethylcarboxylate substituted indoles.
US4943578A (en) Piperazine compounds
US5545644A (en) Indole derivatives
EP1392316B1 (en) Benzo[d]azepine derivatives as 5-ht6 receptor antagonists.
IE59056B1 (en) 4-benzyl-1-(2h)-phthalazinone derivatives
US5607951A (en) Indole derivatives
CA1303047C (en) Imidazolyl indole derivatives
JPH0684370B2 (ja) ムスカリンレセプター拮抗薬
JPH09151174A (ja) ベンゾニトリル類およびベンゾフルオリド類
JPH02138254A (ja) 複素環誘導体
WO1996038420A1 (fr) Derives de l'indazole a groupe amino monocyclique
TW201522330A (zh) ２－醯胺噻唑衍生物或其鹽
US5559129A (en) Indole derivatives
SK116394A3 (en) Substituted phenylcarbamates and ureas
PT94070A (pt) Processo para a preparacao de derivados de piperazina
US5618827A (en) Substituted phenylcarbamates and phenylureas, their preparation and their use as 5-HT antagonists
KR101586507B1 (ko) 아미드 유도체 및 이를 함유하는 약학적 조성물
JP3898219B2 (ja) フエニルインドール化合物
JPH08510263A (ja) ピペリジン誘導体、それらの製造および使用
JPH06503083A (ja) ベンゾフラン及びベンゾチオフェン誘導体
JPH0657693B2 (ja) ムスカリン様レセプター拮抗薬
EP1073651B1 (en) Indolyl derivatives as serotonergic agents
JPH1171350A (ja) ヒドロキシピペリジン化合物およびその剤
JPH111472A (ja) ベンズアミド誘導体及びそれを含有する医薬組成物
JP2004520348A (ja) Ｌｄｌ−受容体発現のインデューサーとしてのアリールピペリジン誘導体